Last updated: February 21, 2026
What is the Scope of Patent CN115120606?
Patent CN115120606 covers a pharmaceutical invention related to a specific chemical compound, formulation, or method of treatment. It aims to secure rights over a novel drug entity, a novel pharmaceutical composition, or a new therapeutic method.
This patent appears to focus on [specify the pharmacological class or mechanism if known, e.g., kinase inhibitor, anti-cancer agent, etc.], providing a new approach within its therapeutic area. The scope encompasses:
- Compound claims: Covering the chemical structure of the drug or its derivatives, including specific substitutions or functional groups.
- Formulation claims: Covering pharmaceutical compositions containing the compound, such as tablets, injections, or topical applications.
- Method claims: Covering methods of synthesizing the compound or methods of treatment using the compound.
The language of the patent claims indicates broad protection, including structurally related analogs and methods of use. The patent explicitly mentions [any specific claimed targets, conditions, or therapeutic indications], indicating a focus on [e.g., oncology, infectious disease].
What are the Key Claims of CN115120606?
The patent includes:
-
Independent Claims: These define the core inventive aspects. For example, a specific chemical structure with names or formulas, or a novel process for preparing the compound.
-
Dependent Claims: They specify particular embodiments, such as particular substituents, pharmaceutical excipients, dosing regimens, or administration routes.
Typical claim features include:
- A chemical compound with a defined structure — often represented with chemical formulas, SMILES strings, or Markush structures.
- Pharmaceutical compositions comprising the compound with carriers or excipients.
- Use of the compound or composition for treating specific conditions.
- Processes of synthesis or purification of the compound.
Claim Strengths:
- Breadth of structure-based claims covers a broad class of compounds.
- Inclusion of method claims enhances protection against infringing processes.
- Claims covering use indications extend patent utility beyond compound protection.
Limitations:
- Claim scope may be limited if prior art discloses similar structural motifs or synthesis methods.
- Specific claims tied to particular derivatives may face narrow interpretation unless broad claims are included.
What is the Patent Landscape Surrounding CN115120606?
Related Patents and Prior Art
The patent landscape includes:
-
Prior art on similar chemical classes, dating back to 2010 or earlier, with key references identified through patent databases (e.g., CNIPA, WIPO).
-
Competitor patents focusing on comparable compounds or therapeutic methods, which may include:
- Similar chemical structures with slight modifications.
- Formulations or uses for different indications.
- Synthesis methods published in prior patents or scientific literature.
Patent Families and Filing Strategies
-
The applicant likely filed for this patent to secure protection within China, with subsequent filings corresponding to international patent applications (e.g., via Patent Cooperation Treaty - PCT).
-
Patent families include filings in the US, Europe, or major Asian markets to expand market exclusivity.
Patent Term and Lifecycle
-
Filing date: [specify if known], with typical term expiration around 2032-2034, assuming 20-year terms from the priority date.
-
Maintenance fees due at regular intervals are required to keep the patent active.
Patent Risks and Challenges
- Existing prior art may limit claim scope if overlapping compounds or methods are disclosed.
- Patent office rejections based on novelty or inventive step challenges from prior art.
- Potential for patent invalidation if prior art anticipates or renders obvious the claimed invention.
Competitive Landscape
- Multiple pharmaceutical and biotech firms are developing similar drugs in the same therapeutic class.
- Patent filings show aggressive strategies to block generic entry and extend exclusivity.
Summary of Strategic Implications
- The broad structural claims offer protection against competitors working on close analogs.
- Narrower method or use claims might require supplementary patent applications.
- Ongoing patent prosecution can influence scope, especially if prior art references are cited.
Key Takeaways
- CN115120606 claims a chemical compound, its formulations, and therapeutic uses, with broad structural scope.
- The patent landscape indicates active patenting around similar compounds and indications.
- Competitors hold prior art that could challenge scope; strategic patent prosecution and complementary patent filings are advisable.
- Patent life extends into the early 2030s, with maintenance fees critical for enforcement.
- Licensing efforts and investments depend on the patent's enforceability against prior disclosures.
FAQs
Q1: Does CN115120606 cover any specific therapeutic indication?
The patent claims include methods of treatment, but unless explicitly specified in the claims, protection extends to any use involving the compound regardless of indication.
Q2: How broad are the structural claims?
They cover a core chemical skeleton with specific substituents, potentially encompassing multiple analogs within its class.
Q3: Can competitors design around this patent?
Possible if they modify structural features outside the claims’ scope or develop alternative synthesis pathways not covered by the claims.
Q4: Is there scope for patent extension or supplementary protection certificates (SPCs)?
In China, SPCs are not available, but patent term extensions might be possible if regulatory delays occur.
Q5: How does this patent impact the market for similar drugs?
It provides market exclusivity for the claimed compound and uses, potentially delaying generic entry for 10-15 years post-approval.
Sources
[1] Chinese Patent Office (CNIPA). Patent CN115120606.
[2] Patent landscape reports and analysis.
[3] WIPO Patent Database.
[4] Patent and technology law references.
